CAS 112093-28-4
:Endoxifen
Description:
Endoxifen is a selective estrogen receptor modulator (SERM) primarily known for its role in breast cancer treatment, particularly in patients with estrogen receptor-positive tumors. It is an active metabolite of tamoxifen, which is commonly used in hormone therapy for breast cancer. Endoxifen exhibits both estrogenic and anti-estrogenic properties, depending on the tissue type, which allows it to inhibit the growth of estrogen-dependent tumors while potentially preserving beneficial estrogenic effects in other tissues. The substance is characterized by its ability to bind to estrogen receptors, modulating gene expression and cellular proliferation. Its pharmacokinetics include oral bioavailability and a relatively long half-life, making it effective in therapeutic regimens. Additionally, endoxifen has been studied for its potential in overcoming resistance to other anti-estrogen therapies. As with many SERMs, the side effects may include hot flashes, risk of thromboembolic events, and other estrogen-related effects, necessitating careful monitoring during treatment.
Formula:C25H27NO2
InChI:InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24-
InChI key:InChIKey=MHJBZVSGOZTKRH-IZHYLOQSSA-N
SMILES:C(=C(/CC)\C1=CC=CC=C1)(\C2=CC=C(OCCNC)C=C2)/C3=CC=C(O)C=C3
Synonyms:- (Z)-4-Hydroxy-N-desmethyl Tamoxifen
- (Z)-Endoxifen
- 4-Hydroxy-N-desmethyltamoxifen
- 4-[(1Z)-1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenol
- 4-[(1Z)-1-{4-[2-(methylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenol
- N-Desmethyl-4-hydroxytamoxifen
- Phenol, 4-[(1Z)-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-
- Phenol, 4-[(1Z)-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]-
- Phenol, 4-[1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]-, (Z)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Endoxifen (Z-isomer)
CAS:Endoxifen Z-isomer (EDX) is a key active metabolite of tamoxifen with higher affinity and specificity to estrogen receptors that inhibits aromatase activity.Formula:C25H27NO2Purity:99.19% - 99.81%Color and Shape:SolidMolecular weight:373.49(Z)-4-Hydroxy-N-desmethyl Tamoxifen (contains up to 10% E isomer)
CAS:Controlled Product<p>Stability Light Sensitive, Temperature Sensitive<br>Applications A novel active metabolite of the anti-cancer drug Tamoxifen (T006000). It showed potent ER binding property, blocked estrogen stimulated growth of breast cancer cell and half maximal inhibition of estrogen responsive gene expression in ER pos. human breast cancer cell line.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Furr, B., et al.: Pharmacol. Ther., 25, 127 (1984), Leonessa, F., et al.: Cancer Res., 54, 441 (1994), Stearns, V., et al.: Lancet, 360, 1851 (2002), Rae, J., et al.: Pharmacogenetics, 13, 501 (2003),<br></p>Formula:C25H27NO2Color and Shape:NeatMolecular weight:373.49Z-Endoxifen
CAS:<p>Z-Endoxifen is the active metabolite of tamoxifen (FT32122, BT164438, FT27994) that acts as an inhibitor of the enzyme aromatase and as inhibitor of the binding of estradiol to estrogen receptors. As an antitumour agent, Z-endoxifen has shown that it has the potential to treat endocrine-resistant estrogen receptor-positive (ER+) breast cancers. Endoxifen is the most effective non-competitive inhibitor of aromatase by conferring molecular rigidity upon binding.</p>Formula:C25H27NO2Purity:Min. 95%Molecular weight:373.49 g/molRef: 4Z-T-019
Discontinued product
